Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms

Background: The present work aimed to investigate the expression of CD160/ CD200 in CLL and other mature B-cell neoplasms (MBN) and their use as an additional diagnostic tool for differentiating CLL from other MBN. Materials and Methods: Using flow cytometry, we detected the expression of CD160 &...

Descripción completa

Detalles Bibliográficos
Autores principales: El- Neanaey, Wafaa Ahmed, Swelem, Rania Shafik, Ghallab, Omar Mohamed, Mohamed Abu-Shelou, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167601/
https://www.ncbi.nlm.nih.gov/pubmed/32337012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167601/
https://www.ncbi.nlm.nih.gov/pubmed/32337012

Ejemplares similares